For rigorous in vitro and preclinical research, high-grade Thymulin should meet or exceed a 98.0% purity threshold verified by RP-HPLC and mass spectrometry. PX1 Research delivers laboratory-grade Thymulin synthesized in the USA, providing lot-specific third-party COAs covering HPLC purity, mass-spec identity confirmation, and endotoxin levels below 0.1 EU/mg, with same-day dispatch M–F from California and Arizona facilities.
For rigorous in vitro and preclinical research, high-grade Thymulin should meet or exceed a 98.0% purity threshold verified by RP-HPLC and mass spectrometry. PX1 Research delivers laboratory-grade Thymulin synthesized in the USA, providing lot-specific third-party COAs covering HPLC purity, mass-spec identity confirmation, and endotoxin levels below 0.1 EU/mg, with same-day dispatch M–F from California and Arizona facilities.
High-purity Thymulin designated for laboratory research must maintain a Reversed-Phase High-Performance Liquid Chromatography (RP-HPLC) purity score of at least 98.0%. This ensures that non-specific peptide fragments or chemical impurities do not interfere with baseline cellular assays.
Mass spectrometry (ESI-MS or MALDI-TOF) must confirm the expected monoisotopic molecular weight of 857.9 Da to verify exact amino acid sequence fidelity. Net peptide content typically ranges between 75% and 85% due to residual moisture and counter-ion trifluoroacetic acid (TFA) salts remaining from synthesis.
Bacterial endotoxin levels should measure strictly below 0.1 EU/mg to prevent unwanted activation of Toll-like receptor pathways in primary cell lines. Every lot should be backed by an independent third-party Certificate of Analysis (COA) documenting raw chromatograms prior to experimental use.
Thymulin (formerly known as Facteur Thymique Sérique or FTS) is a thymic nonapeptide hormone with the amino acid sequence PyroGlu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn. In scientific literature, it is widely investigated for its role in immune system regulation, T-cell differentiation, and thymic factor activity in cellular signaling pathways. Biological activity in preclinical models depends on equimolar binding with zinc ions (Zn2+), which induces a functional conformational change.
For investigators evaluating primary T-cell lineages, thymocyte maturation, or cytokine expression cascades, the chemical purity of the research peptide is paramount. Synthesized deletion sequences, truncated fragments, or residual organic coupling reagents can competitively bind zinc ions or cellular receptors. Utilizing fully characterized Thymulin research peptides ensures that observed signaling dynamics are attributable strictly to the target nonapeptide sequence.
When preparing stock solutions for quantitative assays, using unverified or poorly purified peptide material introduces unaccounted variables. Sourcing 10 mg vials of Thymulin with confirmed analytical purity guarantees precise stoichiometry during zinc coordination and cellular exposure experiments.
Reversed-Phase High-Performance Liquid Chromatography (RP-HPLC) serves as the industry standard for determining overall peptide purity. For high-precision bioassays, structural analysis, and cellular kinetics, the target **thymulin purity percentage** should always be 98.0% or higher based on total peak area integration at 214 nm or 220 nm UV absorbance.
During RP-HPLC testing, the peptide sample is eluted across a hydrophobic stationary phase column (typically C18) using an aqueous-organic solvent gradient containing volatile acid modifiers. A single, sharp principal peak indicates a homogeneous peptide sample, while secondary peaks represent synthesis artifacts, deletion sequences, or degraded fragments. A purity percentage of 98.0% confirms that 98.0% of the total UV absorbance corresponds exclusively to full-length Thymulin.
Lower purity grades (such as 90% or 95%) may contain significant concentrations of closely eluting enantiomeric impurities or truncated peptide chains. In T-cell differentiation assays, these secondary impurities can exhibit partial agonist or antagonist activity, distorting concentration-response curves and lowering baseline experimental reproducibility.
A common pitfall when preparing laboratory reagents is assuming that a 10 mg vial of lyophilized powder represents 10 mg of pure, active peptide sequence. In practice, gross powder mass consists of active nonapeptide molecules, counter-ions acquired during purification, and residual moisture bound to the peptide structure.
During solid-phase peptide synthesis (SPPS) and subsequent RP-HPLC purification, trifluoroacetic acid (TFA) is employed to cleave protecting groups and elute target fractions. As a result, basic amino acid residues (such as Lysine in position 3 of Thymulin) form TFA salts. The Net Peptide Content (NPC)—the mass ratio of actual peptide relative to total solid mass—typically ranges between 75% and 85%. The remaining 15% to 25% consists of TFA counter-ions and bound water of hydration.
To calculate exact molar concentrations for buffer preparations, researchers must multiply total gross mass by both the HPLC purity factor and the Net Peptide Content percentage provided on the lot COA. For example, in a 10 mg Thymulin vial with an 80% NPC and 98.5% HPLC purity, the true active peptide mass is calculated as 10 mg × 0.80 × 0.985 = 7.88 mg. Adjusting working concentrations using these parameters is essential for high-accuracy molecular research.
While RP-HPLC measures sample purity by separating chemical components, Mass Spectrometry (MS) verifies the absolute identity of the target peptide molecule. Liquid Chromatography-Mass Spectrometry (LC-MS) or Matrix-Assisted Laser Desorption/Ionization Time-of-Flight (MALDI-TOF) instruments measure the mass-to-charge ratio (m/z) of the sample ionization state.
The theoretical monoisotopic molecular weight of uncomplexed nonapeptide Thymulin is 857.9 Da (molecular formula: C33H54N12O15). Mass spectrometry reports for validated lots should display a prominent protonated molecular ion peak [M+H]+ at m/z 858.9, or a doubly charged ion peak [M+2H]2+ at m/z 429.95. The observed mass must match theoretical calculations within a tight instrument tolerance (typically ± 0.5 Da).
Mass spectral analysis confirms that the synthetic peptide possesses the correct amino acid composition without missing amino acid additions, unremoved side-chain protecting groups, or unexpected oxidative modifications. Before deploying peptides from our primary catalog of research peptides, verifying mass spectral data guarantees exact sequence fidelity.
Bacterial endotoxins (lipopolysaccharides or LPS) are outer membrane components of Gram-negative bacteria that trigger powerful innate immune responses via Toll-like Receptor 4 (TLR4). Because research on Thymulin focuses heavily on immune system regulation and signal transduction, background endotoxin contamination severely compromises study results.
Quantitative testing using the Chromogenic Limulus Amebocyte Lysate (LAL) assay is required to measure endotoxin content in EU/mg (Endotoxin Units per milligram). For primary cell cultures and in vitro T-cell differentiation studies, endotoxin levels should not exceed 0.1 EU/mg. Higher endotoxin levels induce non-specific inflammatory cytokine release (such as TNF-alpha and IL-6), creating confounding background signal that masks true nonapeptide-mediated activity.
Furthermore, excessive residual TFA can cause micro-environmental pH shifts in poorly buffered culture media and exert cytotoxic effects on primary splenocytes or thymocytes. Ensuring that synthesized peptides undergo thorough lyophylization and low-TFA processing protects sensitive cellular assays from non-specific toxic responses.
A lot-specific third-party Certificate of Analysis (COA) is the definitive proof of peptide quality. When reviewing analytical documentation for research stock, examine each data section systematically:
1. Header and Lot Identification: Verify that the batch or lot number printed on the physical vial label exactly matches the lot number displayed at the top of the COA document.
2. RP-HPLC Integration Table: Check the main peak retention time and integrated area percentage. Confirm that the primary nonapeptide peak represents ≥ 98.0% of total integrated area, with clean baseline separation from secondary peaks.
3. Mass Spectral Output: Review the m/z spectral trace. Confirm the dominant ion peak corresponds to the theoretical mass of 857.9 Da (e.g., [M+H]+ = 858.9 m/z) without unaccounted high-mass impurity clusters.
4. Net Peptide Content (Mass Balance): Ensure the NPC percentage is explicitly stated (typically 75–85%) to allow accurate volumetric recalculations.
5. Endotoxin Quantitation (LAL Assay): Confirm the measured value is clearly reported below 0.1 EU/mg rather than listed as unmeasured or 'N/A'.
6. Physical Characteristics: Ensure description lists a crisp, white to off-white lyophilized cake or powder, which confirms complete moisture sublimation during freeze-drying.
When selecting a vendor for research peptides, relying on marketing claims is insufficient. Lab managers and principal investigators should evaluate suppliers using verifiable analytical criteria:
Purity Verification: PX1 Research enforces a strict ≥ 98.0% RP-HPLC purity threshold backed by raw chromatograms. Discounter suppliers often supply static stock images or unverified > 95% claims without individual peak integration tables.
Sourcing and Synthesis: PX1 Research utilizes USA-based solid-phase peptide synthesis (SPPS) with rigorous step-by-step quality controls. Generic imported materials often suffer from sequence truncation and batch-to-batch variability.
Lot Traceability: Every vial shipped by PX1 Research features an indexed lot number linking directly to an online, downloadable third-party COA. Unvetted sources often share a single COA across multiple distinct manufacturing runs.
Endotoxin Testing: PX1 Research performs quantitative LAL endotoxin testing on every lot intended for cellular work. Competitors routinely omit endotoxin screening to reduce processing costs.
Shipping and Logistics: Cold-chain compatible packaging and same-day dispatch from CA and AZ prevent thermal degradation during transit. Drop-ship resellers expose sensitive freeze-dried powders to prolonged heat exposure.
Researchers studying complementary thymic pathways or regulatory host defense peptides can also examine analytical profiles for related compounds such as Thymosin Alpha-1, Thymosin Beta-4, and antimicrobial signals like LL-37 peptides.
Identifying non-compliant or compromised peptide suppliers is crucial for preventing wasted research budgets and unreliable dataset outcomes. Maintain caution if you encounter any of the following commercial red flags:
Missing Lot-Specific Chromatograms: Suppliers that provide a single PDF certificate for all orders without corresponding lot numbers on physical vial labels.
Vague Purity Claims: Product listings using vague terminology like 'research grade' or 'maximum purity' without defining an exact RP-HPLC numerical percentage.
Omission of Mass Spectrometry: Vendors unable to provide raw m/z spectra confirming target molecular mass (857.9 Da).
Medical or Administration Guidelines: Websites offering human dosage calculators, therapeutic claims, or injection instructions violate regulatory RUO guidelines and indicate non-compliant supply chain practices.
Unusually Low Pricing: Prices significantly below standard solid-phase synthesis production costs indicate crude, unpurified mixtures, missing TFA removal steps, or mislabeled peptide sequence variants.
To review full quality standards and raw testing data across our research catalog, consult the comprehensive documentation in our research library.
PX1 Research supplies premium, laboratory-grade 10 mg Thymulin vials formulated specifically for demanding in vitro and preclinical research applications. Each production lot is synthesized in the USA and subjected to rigorous independent analytical testing, including RP-HPLC purity verification (≥ 98.0%), mass spectrometry identity matching, and quantitative LAL endotoxin analysis.
Orders placed prior to 2:00 PM PST Monday through Friday dispatch same-day from our California and Arizona logistics facilities. Lyophilized peptide vials are packaged in secure, cold-chain ready insulated shipping materials with tamper-evident seals to ensure absolute compound stability upon arrival at your facility.
Every shipment includes direct access to lot-indexed COAs. Institutional buyers requiring larger quantities or specialized contract batch sizes can submit requests via our dedicated wholesale peptide program. To secure fully validated nonapeptide material for your laboratory, order 10 mg vials of Thymulin directly from PX1 Research.
What is the standard thymulin purity percentage for in vitro studies?
The standard thymulin purity percentage for in vitro cellular studies is 98.0% or higher as measured by RP-HPLC. High purity ensures that deletion sequences, unreacted coupling reagents, and secondary peptide impurities do not interfere with cellular signaling assays, zinc binding dynamics, or T-cell differentiation models.
Is Thymulin legally available for laboratory research in the US?
Yes, Thymulin is legally available in the United States strictly as a research chemical for in vitro and preclinical laboratory experimentation. It is not approved for human consumption, therapeutic use, or clinical administration. Academic and private laboratory buyers can order verified research lots directly from accredited suppliers like PX1 Research.
What is the molecular weight of Thymulin verified on a mass spec?
The theoretical monoisotopic molecular weight of unbound nonapeptide Thymulin is 857.9 Da. On a high-resolution mass spectrometer (ESI-MS or MALDI-TOF), verified samples exhibit a primary protonated molecular ion peak [M+H]+ at m/z 858.9, matching the chemical formula C33H54N12O15.
How does net peptide content affect Thymulin concentration calculations?
Net peptide content (NPC) measures actual active peptide mass relative to total gross lyophilized weight, which includes residual TFA counter-ions and bound water. Because NPC typically ranges between 75% and 85%, researchers must multiply total powder weight by the NPC factor and HPLC purity percentage to calculate accurate working solution concentrations.
Why is endotoxin testing critical when evaluating Thymulin quality?
Endotoxin testing ensures that background bacterial lipopolysaccharides (LPS) do not trigger unwanted innate immune responses via TLR4 receptors. Because Thymulin is actively researched for its role in immune signaling and cytokine modulation, endotoxin levels must remain below 0.1 EU/mg to prevent false-positive experimental outcomes.
Does PX1 Research provide a lot-specific COA with every Thymulin order?
Yes, PX1 Research provides a downloadable, lot-specific third-party Certificate of Analysis with every Thymulin order. Each COA includes complete RP-HPLC purity chromatograms, mass spectrometry molecular weight confirmation, net peptide content determinations, and LAL endotoxin quantification.
How fast does PX1 Research ship Thymulin orders?
Orders placed before 2:00 PM PST Monday through Friday dispatch same-day from PX1 Research fulfillment facilities in California and Arizona. Packages are shipped using expedited domestic carrier services with tracking and cold-chain compatible protective packaging.
How should lyophilized Thymulin be stored upon delivery?
Lyophilized Thymulin powder should be stored in a freezer at -20°C or -80°C upon arrival to maintain long-term peptide stability. Desiccated freezing preserves peptide integrity for extended periods. Once reconstituted in sterile, buffered aqueous solution, aliquots should be frozen to avoid repeated freeze-thaw cycles.
What is the role of zinc in Thymulin peptide activity?
Preclinical studies show that Thymulin requires zinc (Zn2+) in an equimolar 1:1 ratio to assume its biologically active conformation. Uncomplexed Thymulin lacks structural binding affinity for target cell receptors, making equimolar zinc coordination essential when designing functional in vitro bioassays.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.